Trinity Financial Advisors’s AbbVie ABBV Stock Holding History

Trinity Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$274K	Sell	1,049 -22	-2%	-$5.64K	0.07%	83
2026 Q2	$269K	Buy	1,071 +53	+5%	+$11.4K	0.07%	81
2026 Q1	$221K	Buy	1,018 +2	+0.2%	+$444	0.06%	84
2025 Q4	$232K	Sell	1,016 -127	-11%	-$28.9K	0.06%	87
2025 Q3	$265K	Buy	+1,143	New	+$233K	0.08%	85
2024 Q1	–	Sell	-1,298	Closed	-$201K	–	74
2023 Q4	$201K	Sell	1,298 -2,089	-62%	-$305K	0.1%	73
2023 Q3	$505K	Sell	3,387 -754	-18%	-$111K	0.27%	36
2023 Q2	$558K	Sell	4,141 -921	-18%	-$135K	0.3%	32
2023 Q1	$807K	Buy	5,062 +751	+17%	+$115K	0.49%	19
2022 Q4	$697K	Buy	4,311 +282	+7%	+$43.2K	0.46%	25
2022 Q3	$541K	Buy	+4,029	New	+$578K	0.39%	31

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Trinity Financial Advisors's ABBV Position: Q3 2026 in Review

Trinity Financial Advisors reduced its AbbVie (ABBV) stake by 2.1% in Q3 2026, selling an estimated $5.64K and leaving 1,049 shares worth $274K. The position accounts for 0.07% of the portfolio, ranked #83.

Trinity Financial Advisors first reported a position in ABBV in Q3 2022 and has held it in 11 quarters since. The position peaked at $807K in Q1 2023. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Trinity Financial Advisors held 1,049 shares of AbbVie worth $274K as of Q3 2026.
Trinity Financial Advisors sold 22 AbbVie shares in Q3 2026, an estimated $5.64K.
AbbVie made up 0.07% of Trinity Financial Advisors's portfolio in Q3 2026, its #83 holding.
Trinity Financial Advisors first reported a position in AbbVie in Q3 2022 and has held it in 11 quarters since.
Trinity Financial Advisors's AbbVie position peaked at $807K in Q1 2023.
2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Trinity Financial Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.